Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Anesthesia

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1894525

Cover Image

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1894525

Inhalation Anesthetics

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Inhalation Anesthetics Market to Reach US$2.0 Billion by 2030

The global market for Inhalation Anesthetics estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Sevoflurane, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Desflurane segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$418.7 Million While China is Forecast to Grow at 3.6% CAGR

The Inhalation Anesthetics market in the U.S. is estimated at US$418.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$309.0 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Inhalation Anesthetics Market - Key Trends & Drivers Summarized

What Are Inhalation Anesthetics, and What Role Do They Play in Modern Medicine?

Inhalation anesthetics are gases or volatile liquids that are administered to patients during surgical procedures to induce and maintain general anesthesia. These substances, which include agents such as isoflurane, sevoflurane, and desflurane, are preferred in many surgical settings due to their rapid onset and easy reversibility. Their ability to control the depth of anesthesia with adjustments in concentration and flow rates makes them indispensable in ensuring patient safety and comfort during operations. The administration of inhalation anesthetics is typically conducted through modern anesthesia machines that allow for precise control over dosage and mixture with oxygen, which is critical for patient safety.

How Are Advancements in Medical Practices Enhancing the Use of Inhalation Anesthetics?

Advancements in medical practices and surgical techniques have greatly influenced the development and use of inhalation anesthetics. The trend towards minimally invasive surgeries, which require shorter recovery times and reduce the risk of complications, has supported the demand for anesthetics that are easy to administer and adjust. Developments in monitoring technology have also improved the safety of using inhalation anesthetics, enabling anesthesiologists to maintain optimal sedation levels while monitoring vital signs to prevent adverse reactions. Furthermore, ongoing research into the pharmacological properties of inhalation anesthetics is leading to the formulation of newer agents that are less likely to cause side effects and are more environmentally friendly.

What Challenges Are Faced by the Inhalation Anesthetics Market?

The inhalation anesthetics market faces challenges related to the side effects and environmental impact of anesthetic gases. Some inhalation anesthetics are known to contribute to greenhouse gas emissions, which poses environmental and regulatory challenges. Additionally, concerns about the neurotoxicity of some anesthetics, particularly in vulnerable populations such as infants and the elderly, call for more research and careful management. However, these challenges drive the development of new anesthetic formulations and delivery systems that are safer for patients and less harmful to the environment. The adoption of closed-loop anesthesia systems, which reduce wastage and minimize exposure to healthcare workers, is one such innovation that addresses both safety and environmental concerns.

Growth in the Inhalation Anesthetics Market Is Driven by Several Factors…

The growth in the inhalation anesthetics market is driven by several factors, including the increasing number of surgical procedures globally, which directly correlates with the rising demand for effective anesthetic agents. Technological advancements in anesthesia delivery systems, which enhance the safety and efficacy of inhalation anesthetics, also contribute to market growth. Moreover, the expanding elderly population, which is more prone to chronic diseases requiring surgical interventions, supports the sustained demand for inhalation anesthetics. Economic factors, such as the growing healthcare expenditure in emerging economies and the development of healthcare infrastructure, further drive the market. Additionally, ongoing research into safer and more efficient anesthetic agents continues to open new avenues for market expansion. Collectively, these factors ensure a robust growth trajectory for the inhalation anesthetics market, reflecting its crucial role in facilitating safe surgical care.

SCOPE OF STUDY:

The report analyzes the Inhalation Anesthetics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Sevoflurane, Desflurane, Nitrous Oxide, Isoflurane); Application (Maintenance, Induction)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • 058 LatchGas
  • Abbott Laboratories, Inc.
  • AbbVie, Inc.
  • Accutron
  • Baxter International, Inc.
  • Chester County Family Dentistry
  • Discover Dental
  • Eisai Co., Ltd.
  • Fox Family Dentistry
  • Fresenius Kabi AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP12727

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Inhalation Anesthetics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Anesthetic Delivery Systems Propel Development of Next-Generation Inhalation Anesthetics
    • Rising Demand for Outpatient Surgeries Spurs Growth in Inhalation Anesthetics Market
    • Increasing Adoption of Inhalation Anesthetics in Ambulatory Surgical Centers Expands Market Potential
    • Growth in Geriatric Population Drives Demand for Safe and Effective Anesthesia Solutions
    • Rising Focus on Patient Safety and Postoperative Outcomes Strengthens Business Case for Inhalation Anesthetics
    • The Role of Inhalation Anesthetics in Enhancing Efficiency of Shorter Surgical Procedures Fuels Market Growth
    • Growing Adoption of Inhalation Anesthetics in Pediatric Surgeries Expands Addressable Market
    • Increasing Use of Inhalation Anesthetics in Veterinary Medicine Generates Demand in Non-Human Applications
    • Rising Incidence of Chronic Diseases Requiring Surgical Interventions Propels Growth in Inhalation Anesthetics
    • The Impact of Technological Innovations in Anesthesia Machines on the Inhalation Anesthetics Market
    • Focus on Reducing Environmental Impact Drives Innovation in Eco-Friendly Inhalation Anesthetics
    • Growing Investments in Healthcare Infrastructure in Emerging Markets Expands Market for Inhalation Anesthetics
    • Increasing Research on the Long-Term Effects of Anesthetics Creates Opportunities for Safer Formulations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Inhalation Anesthetics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Inhalation Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Inhalation Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Inhalation Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sevoflurane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sevoflurane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Sevoflurane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Desflurane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Desflurane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Desflurane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Nitrous Oxide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Nitrous Oxide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Nitrous Oxide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Isoflurane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Isoflurane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Isoflurane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Maintenance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Maintenance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Maintenance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Induction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Induction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Induction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • JAPAN
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • CHINA
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • EUROPE
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Inhalation Anesthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Inhalation Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • FRANCE
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • GERMANY
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Inhalation Anesthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Inhalation Anesthetics by Product - Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Inhalation Anesthetics by Product - Percentage Breakdown of Value Sales for Sevoflurane, Desflurane, Nitrous Oxide and Isoflurane for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Inhalation Anesthetics by Application - Maintenance and Induction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Inhalation Anesthetics by Application - Maintenance and Induction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Inhalation Anesthetics by Application - Percentage Breakdown of Value Sales for Maintenance and Induction for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!